Six hundred and thirty-two isolates of Pseudomonas aeruginosa of 17 pyocin types were collected in 1993 in Taiwan. Types 1, 10, 3, 35 and 12 were the most common pyocin types identified in Taiwan with isolation frequencies of 47.3%, 24.4%, 7.6%, 3.6% and 2.2%, respectively. Several pyocin subtypes were determined. All pyocin types (one isolate of each tested) were resistant to ampicillin and nalidixic acid, but sensitive to fluoroquinolone antibiotics, such as norfloxacin and enoxacin, indicating that cross-resistance to quinolone antibiotics of nalidixic acid and fluoroquinolone derivatives has not developed. A new ampicillin derivative of 6,7-difluoroquinolonic acid, N-(6,7-difluoroquinolonyl)-ampicillin (AU-1), was synthesized by coupling ampicillin with 6,7-difluoroquinolonic acid (FP-3). Compound AU-1 was much more active than either ampicillin or FP-3 alone against all pyocin types of P. aeruginosa and induced filamentation in most growing cells.
Introduction
Pseudomonas aeruginosa is an important nosocomial pathogen. 1, 2 Moreover, wounds from burns, malignancy, and surgery are often colonized and subsequently infected with this bacterium. Most infections caused by this bacterium are associated with high rates of morbidity and mortality. [3] [4] [5] The identification schemes designed for this organism in clinical microbiology laboratories are based on biochemical tests and antimicrobial susceptibility patterns. For epidemiological studies, typing systems such as phage typing, serotyping and pyocin typing 2, 6, 7 have been used. However, the elaborate work required to maintain phage typing preparations has limited its use 8 and serotyping is unsatisfactory for mucoid strains. 6 Because of its ease of interpretation and high reproducibility, 5 pyocin typing is the choice for typing P. aeruginosa.
Ampicillin and quinolones are potent antimicrobial agents against a broad spectrum of bacterial species. As a result of the misuse of antibiotics in Taiwan, strains of P. aeruginosa resistant to these antibiotics have developed rapidly. Studies on pyocin typing of P. aeruginosa have been reported by many investigators in various countries, 6 ,7,9-11 but not in Taiwan. Thus, this study was designed to characterize P. aeruginosa isolated in Taiwan by the pyocin typing method and to examine the susceptibility of these organisms to the newly synthesized ampicillin derivative, N- (6,7-difluoroquinolonyl) -ampicillin (AU-1), which was synthesized by coupling ampicillin with 6,7-difluoroquinolonic acid (FP-3) in our laboratory.
Materials and methods

Pyocin typing
Six hundred and thirty-two isolates of P. aeruginosa, collected from the Tri-Service General Hospital in Taiwan from January to June 1993, were maintained in a 20% glycerol tryptic soy broth (BBL, Cockeysville, MD, USA) at 70°C. Before testing, isolates were cultured on nutrient agar (Difco, Detroit, MI, USA). The indicator strains 1-8, A-E and pyocin producer strains 5074 and PP430 9 organisms in 1 mL of sterile physiological saline. A Steers replicator (AutoMed Inc., Arden Falls, MN, USA) with 37 stainless steel pins was used to dispense 1 L of the bacterial suspension on to a set of 13 plates (9 cm in diameter), each containing 10 mL of Mueller-Hinton agar (BBL). After the spots had dried, the plates were incubated at 30°C for 6 h and were placed over filter paper discs (7 cm in diameter; Whatman Inc., Maidstone, UK) that had been impregnated previously with chloroform for 15 min to allow the chloroform vapour to kill the bacteria. The plates were then exposed to air for another 15 min to eliminate residual chloroform vapour. The indicator strains were grown without agitation in Tryptic Soy Broth (BBL) for 4 h at 35°C until they reached a density of 10 7 organisms per mL. One hundred microlitres of the indicator strain culture was then mixed with 2.5 mL of molten, semisolid Tryptic Soy agar (0.5% agar in Tryptic Soy Broth, BBL) held at 50°C and poured into the plates as overlays. When the overlays had settled, the plates were incubated for 18 h at 35°C and the pyocin types were determined. Inhibition zones due to R-or F-type pyocins, ranging from 2 to 3 mm in diameter, had a sharp edge, while S-type pyocin, producing zones of 6-8 mm in diameter, often had a diffuse edge. Each experiment was performed in duplicate.
Susceptibility of
Preparation and chemistry of AU-1
3,4-Difluoroaniline, N,N-dimethylformamide, DMSO, methanol and ethyl acetate were purchased from E. Merck (Frankfurt, Germany). 1-Hydroxybenzotriazole was purchased from Aldrich (Milwaukee, WI, USA). The synthetic AU-1 is an ampicillin derivative that was prepared in our laboratory. The process for synthesizing compound AU-1 was carried out as shown in Figure 1 . First, 3,4-difluoroaniline was used to synthesize 6,7-difluoroquinolonic acid (FP-3) as described by Koga et al. 12 Then, the carboxylic acid of the FP-3 was activated by 1-hydroxybenzotriazole (HOBT) to obtain the mixed anhydride ester. The coupling of ampicillin with this intermediate in N,N-dimethylformamide gave the quinolonylampicillin product in moderate yield. After synthesis and purification, the product was subjected to instrumental analyses. UV spectra were obtained on a Cary 4 spectrophotometer. Nuclear magnetic resonance (NMR) spectra were determined at 300 MHz on a Varian VXR-300 spectrometer using tetramethylsilane (TMS) as an internal standard. Infrared spectra were recorded on a Bio-Rad F60 spectrophotometer. Fast atom bombardment mass spectrometry (FAB-MS) spectra were taken on a Jeol JMS-HX110 mass spectrometer. Melting points were obtained with an electrothermal melting point apparatus. 
Determination of antibacterial activities
The antibiotics including nalidixic acid, enoxacin, norfloxacin and ampicillin were obtained from Sigma (St Louis, MO, USA). Compounds FP-3 and AU-1 were newly synthesized in our laboratory. Stock solutions of the antibiotics were prepared as suggested by the manufacturer and stored at 20°C. Before the experiment, the antibiotic solutions were diluted in Mueller-Hinton agar (BBL) and used immediately. MICs of one isolate of each pyocin type were determined by serial agar dilution with an inoculum of 10 5 cfu of the test organism dispensed by a Steers replicator (AutoMed Inc
Morphology
Mid-log-phase cells of one isolate of each pyocin type were grown in the presence or absence of antibiotics at a concentration equal to the MIC of the particular isolate. Gram's staining was performed, and the morphology of the organisms was observed in a light microscope (Leitz, dialux 22EB) at 1000 magnification.
Results and discussion
Pyocin types
The most common pyocin types of P. aeruginosa i s o l a t e d in Taiwan were types 1, 10, 3, 35 and 12, with frequencies of 47.3%, 24.4%, 7.6%, 3.6% and 2.2%, respectively (Table I) . Of the 632 clinical isolates typed, 2.2% were not included in the types described by Govan 1 3 and 3.5% produced insufficient pyocin for comparison with indicator strains. We identified 17 main types of P. aeruginosa, although several subtypes were determined (Table I ). All pyocin subtypes possessed different patterns of S-type pyocin (data not shown). The distribution of the predominant pyocin types from this study is similar to those reported in Singapore 8 and Australia, 1 4 but different from those reported in the UK 9 and Germany. 1 3 Pyocins have been designated as R, F or S, based on their physicochemical nature and ultrastructure. The R-pyocins a r e high molecular weight substances and are nondiffusible a n d trypsin-resistant. In contrast, S-pyocins are of low mole c u l a r weight and are diffusible and trypsin-sensitive. 1 0 , 1 5 In this study, various distinguishable 'S-type pattern' types were observed. The most common types were S5, S3.6.7 and S3.6.7.B. Detection of S-type pyocin activity by the spotting method allowed further subdivision of the main types and made pyocin typing a much more powerful method.
, 1 6
Physicochemical properties of AU-1
The physicochemical properties of AU-1 and its structure are shown in Table II and Figure 1 . At room temperature, it is insoluble in H 2 O, partially soluble in acetone and ethyl acetate and freely soluble in DMSO, methanol and alkaline solution. Unusually, it is stable at temperatures below 5°C.
Susceptibility of P. aeruginosa to quinolone antibiotics and compound AU-1
The susceptibilities of one isolate of each pyocin type of P. aeruginosa to nalidixic acid, norfloxacin, enoxacin 17 , FP-3, ampicillin and compound AU-1 were determined. In the present study, all pyocin types of P. aeruginosa were highly resistant to nalidixic acid, FP-3 and ampicillin with MICs of 128 g/L. However, isolates had lower MICs of norfloxacin (range 0.5-4 g/L), enoxacin (range 0.5-8 g/L), and AU-1 (range 4-16 g/L). These data indicate that 6-fluoroquinolones are still potent antibiotics against nosocomial P. aeruginosa, one of the most resistant bacteria causing infections in Taiwan. However, resistant strains of P. aeruginosa have increased, as reported since the introduction of norfloxacin and ofloxacin. 18, 19 Resistance to the quinolones is most likely a result of alteration of the subunit of DNA gyrase, or reduction of the drug accumulation in association with changes in bacterial outer membrane proteins. [19] [20] [21] Tenney and his associates reported that spontaneous mutations in the gyrA locus of E. coli resulting in high-level resistance to nalidixic acid could produce cross-resistance to the fluoroquinolone. 22 Nevertheless, cross-resistance between nalidixic acid and 6-fluoroquinolones was not observed in all pyocin types of wild-type P. aeruginosa examined in this study (data not shown). This result is attributed to the fact that P. aeruginosa is intrinsically resistant to nalidixic acid. 23 Ampicillin had no activity against any of the pyocin types tested. This could be because P. aeruginosa possesses a chromosomallymediated inducible -lactamase that acts primarily on cephalosporins and penicillin. 24 Interestingly, the newly synthesized AU-1 was much more active against all pyocin types of P. aeruginosa than either ampicillin or FP-3 alone. This result demonstrated that the FP-3 moiety appended to the -amino group of ampicillin enhanced the antibacterial activity against various types of P. aeruginosa. This could be because the -lactam ring of ampicillin was protected from -lactamase by the FP-3 moiety or because of the increased affinity and penetrating power to the cell membrane of P. aeruginosa by the lipophilic FP-3 moiety. On the other hand, AU-1 at concentrations equal to the MIC, caused unusual filamentation in growing cells of most strains of P. aeruginosa except those of the 1/c, 10/h and 49/f subtypes. Ampicillin and FP-3 did not induce filamentation at the concentration of 128 g/mL. Figure 2 illustrates the typical morphology of the pyocin type 5/f after treatment with both ampicillin and AU-1. In AU-1-exposed cultures, extremely elongated cells without septa were produced. It has been reported that filamentation in growing cells of E.
c o l i could be induced by most cephalosporins that inhibit PBP3, a peptidoglycan transpeptidase involved in separation and also by quinolones that stabilize the cleavable complex of a transient double-strand break in DNA caused by gyrase-catalysed reaction. 2 5 -2 7 However, at present, the information on filamentation in P. aeruginosa is not available and further studies on the action of AU-1 on cell division and cell elongation in P. aeruginosa are planned. In summary, the susceptibility of P. aeruginosa to a newly synthesized ampicillin derivative of 6,7-difluoro- , Chemical shift; s, single peak; J, coupling constant; d, doublet peak; dd, double-doublet peak.
quinolonic acid, AU-1, has been examined. The key finding was the greater antipseudomonas activity of AU-1 compared with ampicillin and 6,7-difluoroquinolonic acid, neither of which had activity against P. aeruginosa. 
